Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Gusperimus trihydrochloride

EU orphan designation number: EU/3/01/034   
Active ingredient: Gusperimus trihydrochloride
Indication: Treatment of Wegener’s granulomatosis
Sponsor: Nordic Group B.V.
Siriusdreef 22, NL-2132 WT Hoofddorp, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/03/2001 Centralised Orphan - Designation EMEA/OD/057/00 (2001)947 of 29/03/2001
07/11/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/057/00/T/01 (2011)7905 of 27/10/2011